Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Increase (Decrease) in Employee Related Liabilities

EMERGENT BIOSOLUTIONS INC. Increase (Decrease) in Employee Related Liabilities

EMERGENT BIOSOLUTIONS INC. (EBS) reported Increase (Decrease) in Employee Related Liabilities of -$16.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-06

  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $4.20M, a 28.81% decline year-over-year.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$20.20M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $4.50M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $4.50M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for fiscal 2025 was -$17.30M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for fiscal 2024 was -$18.20M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for fiscal 2023 was -$10.40M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for fiscal 2022 was -$800.00K, a 120.00% decline from fiscal 2021.
Period endIncrease (Decrease) in Employee Related Liabilities 3 monthIncrease (Decrease) in Employee Related Liabilities 3 month as first filedIncrease (Decrease) in Employee Related Liabilities 6 monthIncrease (Decrease) in Employee Related Liabilities 6 month as first filedIncrease (Decrease) in Employee Related Liabilities 9 monthIncrease (Decrease) in Employee Related Liabilities 9 month as first filedIncrease (Decrease) in Employee Related Liabilities 12 monthIncrease (Decrease) in Employee Related Liabilities 12 month as first filed
2026-06-30$4.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$16.00M
10-Q · filed 2026-08-06
-$11.50M
derived: sum of 3 quarters · filed 2026-08-06
-$7.00M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$20.20M
10-Q · filed 2026-05-01
-$15.70M
derived: sum of 2 quarters · filed 2026-05-01
-$11.20M
derived: sum of 3 quarters · filed 2026-05-01
-$5.30M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$4.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$9.00M
derived: sum of 2 quarters · filed 2026-02-27
$14.90M
derived: sum of 3 quarters · filed 2026-08-06
-$17.30M
10-K · filed 2026-02-27
2025-09-30$4.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$10.40M
derived: sum of 2 quarters · filed 2026-08-06
-$21.80M
10-Q · filed 2025-10-30
-$30.10M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$5.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$26.30M
10-Q · filed 2026-08-06
-$34.60M
derived: sum of 3 quarters · filed 2026-08-06
-$37.50M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$32.20M
10-Q · filed 2026-05-01
-$40.50M
derived: sum of 2 quarters · filed 2026-05-01
-$43.40M
derived: sum of 3 quarters · filed 2026-05-01
-$17.10M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31-$8.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$11.20M
derived: sum of 2 quarters · filed 2026-02-27
$15.10M
derived: sum of 3 quarters · filed 2026-02-27
-$18.20M
10-K · filed 2026-02-27
2024-09-30-$2.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$23.40M
derived: sum of 2 quarters · filed 2025-10-30
-$9.90M
10-Q · filed 2025-10-30
-$19.50M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$26.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$7.00M
10-Q · filed 2025-08-07
-$16.60M
derived: sum of 3 quarters · filed 2026-02-27
-$5.00M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31-$33.30M
10-Q · filed 2025-05-08
-$42.90M
derived: sum of 2 quarters · filed 2026-02-27
-$31.30M
derived: sum of 3 quarters · filed 2026-02-27
-$19.40M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31-$9.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$2.00M
derived: sum of 2 quarters · filed 2026-02-27
$13.90M
derived: sum of 3 quarters · filed 2026-02-27
-$10.40M
10-K · filed 2026-02-27
2023-09-30$11.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$23.50M
derived: sum of 2 quarters · filed 2024-11-07
-$800.00K
10-Q · filed 2024-11-07
$4.10M
derived: sum of 4 quarters · filed 2025-03-04
2023-06-30$11.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$12.40M
10-Q · filed 2024-08-07
-$13.40M
10-Q · filed 2023-08-09
-$7.50M
derived: sum of 3 quarters · filed 2025-03-04
$900.00K
derived: sum of 4 quarters · filed 2025-03-04
2023-03-31-$24.30M
10-Q · filed 2024-05-02
-$25.30M
10-Q · filed 2023-05-10
-$19.40M
derived: sum of 2 quarters · filed 2025-03-04
-$11.00M
derived: sum of 3 quarters · filed 2025-03-04
$7.10M
derived: sum of 4 quarters · filed 2025-03-04
2022-12-31$4.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04
$13.30M
derived: sum of 2 quarters · filed 2025-03-04
$31.40M
derived: sum of 3 quarters · filed 2025-03-04
-$800.00K
10-K · filed 2025-03-04
$100.00K
10-K · filed 2023-03-01
2022-09-30$8.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11
$26.50M
derived: sum of 2 quarters · filed 2023-12-11
-$5.70M
10-Q · filed 2023-12-11
$9.40M
derived: sum of 4 quarters · filed 2024-03-08
2022-06-30$18.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$14.10M
10-Q · filed 2023-08-09
$1.00M
derived: sum of 3 quarters · filed 2024-03-08
$11.30M
derived: sum of 4 quarters · filed 2024-03-08
2022-03-31-$32.20M
10-Q · filed 2023-05-10
-$17.10M
derived: sum of 2 quarters · filed 2024-03-08
-$6.80M
derived: sum of 3 quarters · filed 2024-03-08
$1.20M
derived: sum of 4 quarters · filed 2024-03-08
2021-12-31$15.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
$25.40M
derived: sum of 2 quarters · filed 2024-03-08
$33.40M
derived: sum of 3 quarters · filed 2024-03-08
$4.00M
10-K · filed 2024-03-08
2021-09-30$10.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$18.30M
derived: sum of 2 quarters · filed 2022-11-09
-$11.10M
10-Q · filed 2022-11-09
-$3.80M
derived: sum of 4 quarters · filed 2023-12-11
2021-06-30$8.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
-$21.40M
10-Q · filed 2022-08-02
-$14.10M
derived: sum of 3 quarters · filed 2023-12-11
$3.80M
derived: sum of 4 quarters · filed 2023-12-11
2021-03-31-$29.40M
10-Q · filed 2022-04-29
-$22.10M
derived: sum of 2 quarters · filed 2023-12-11
-$4.20M
derived: sum of 3 quarters · filed 2023-12-11
$7.30M
derived: sum of 4 quarters · filed 2023-12-11
2020-12-31$7.30M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11
$25.20M
derived: sum of 2 quarters · filed 2023-12-11
$36.70M
derived: sum of 3 quarters · filed 2023-12-11
$21.80M
10-K/A · filed 2023-12-11
2020-09-30$17.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$29.40M
derived: sum of 2 quarters · filed 2021-11-05
$14.50M
10-Q · filed 2021-11-05
$21.10M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$11.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
-$3.40M
10-Q · filed 2021-07-30
$3.20M
derived: sum of 3 quarters · filed 2022-02-25
$14.30M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31-$14.90M
10-Q · filed 2021-04-30
-$8.30M
derived: sum of 2 quarters · filed 2022-02-25
$2.80M
derived: sum of 3 quarters · filed 2022-02-25
$10.60M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$6.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$17.70M
derived: sum of 2 quarters · filed 2022-02-25
$25.50M
derived: sum of 3 quarters · filed 2022-02-25
$4.20M
10-K · filed 2022-02-25
2019-09-30$11.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$18.90M
derived: sum of 2 quarters · filed 2020-11-06
-$2.40M
10-Q · filed 2020-11-06
$2.10M
derived: sum of 4 quarters · filed 2021-02-19
2019-06-30$7.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
-$13.50M
10-Q · filed 2020-07-31
-$9.00M
derived: sum of 3 quarters · filed 2021-02-19
$3.50M
derived: sum of 4 quarters · filed 2021-02-19
2019-03-31-$21.30M
10-Q · filed 2020-05-01
-$16.80M
derived: sum of 2 quarters · filed 2021-02-19
-$4.30M
derived: sum of 3 quarters · filed 2021-02-19
$500.00K
derived: sum of 4 quarters · filed 2021-02-19
2018-12-31$4.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$17.00M
derived: sum of 2 quarters · filed 2021-02-19
$21.80M
derived: sum of 3 quarters · filed 2021-02-19
$8.40M
10-K · filed 2021-02-19
2018-09-30$12.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$17.30M
derived: sum of 2 quarters · filed 2019-11-07
$3.90M
10-Q · filed 2019-11-07
$3.92M
10-Q · filed 2018-11-02
$9.10M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$4.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
-$8.60M
10-Q · filed 2019-08-02
-$8.62M
10-Q · filed 2018-08-03
-$3.40M
derived: sum of 3 quarters · filed 2020-02-25
$4.89M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31-$13.40M
10-Q · filed 2019-05-08
-$13.37M
10-Q · filed 2018-05-04
-$8.20M
derived: sum of 2 quarters · filed 2020-02-25
$94.00K
derived: sum of 3 quarters · filed 2020-02-25
$1.10M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$5.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$13.49M
derived: sum of 2 quarters · filed 2020-02-25
$14.50M
derived: sum of 3 quarters · filed 2020-02-25
$3.30M
10-K · filed 2020-02-25
$3.35M
10-K · filed 2018-02-23
2017-09-30$8.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$9.30M
derived: sum of 2 quarters · filed 2018-11-02
-$1.90M
10-Q · filed 2018-11-02
$450.00K
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$1.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
-$10.19M
10-Q · filed 2018-08-03
-$7.84M
derived: sum of 3 quarters · filed 2019-02-22
-$3.03M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31-$11.20M
10-Q · filed 2018-05-04
-$8.85M
derived: sum of 2 quarters · filed 2019-02-22
-$4.04M
derived: sum of 3 quarters · filed 2019-02-22
-$726.00K
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31$2.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$7.17M
derived: sum of 2 quarters · filed 2019-02-22
$10.48M
derived: sum of 3 quarters · filed 2019-02-22
$2.20M
10-K · filed 2019-02-22
$2.24M
10-K · filed 2017-02-28
2016-09-30$4.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$8.13M
derived: sum of 2 quarters · filed 2017-11-03
-$152.00K
10-Q · filed 2017-11-03
$4.22M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$3.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
-$4.97M
10-Q · filed 2017-08-04
-$598.00K
derived: sum of 3 quarters · filed 2018-02-23
$3.19M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31-$8.28M
10-Q · filed 2017-05-05
-$3.91M
derived: sum of 2 quarters · filed 2018-02-23
-$124.00K
derived: sum of 3 quarters · filed 2018-02-23
$5.29M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$4.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$8.15M
derived: sum of 2 quarters · filed 2018-02-23
$13.56M
derived: sum of 3 quarters · filed 2018-02-23
$2.68M
10-K · filed 2018-02-23
2015-09-30$3.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$9.20M
derived: sum of 2 quarters · filed 2016-11-09
-$1.69M
10-Q · filed 2016-11-09
$3.06M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$5.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
-$5.47M
10-Q · filed 2016-08-05
-$726.00K
derived: sum of 3 quarters · filed 2017-02-28
$2.97M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31-$10.88M
10-Q · filed 2016-05-06
-$6.14M
derived: sum of 2 quarters · filed 2017-02-28
-$2.44M
derived: sum of 3 quarters · filed 2017-02-28
$2.38M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$4.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$8.44M
derived: sum of 2 quarters · filed 2017-02-28
$13.26M
derived: sum of 3 quarters · filed 2017-02-28
$4.54M
10-K · filed 2017-02-28
2014-09-30$3.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$8.51M
derived: sum of 2 quarters · filed 2015-11-06
-$208.00K
10-Q · filed 2015-11-06
$6.05M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$4.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$3.90M
10-Q · filed 2015-08-06
$2.35M
derived: sum of 3 quarters · filed 2016-02-29
$5.32M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$8.72M
10-Q · filed 2015-05-08
-$2.46M
derived: sum of 2 quarters · filed 2016-02-29
$502.00K
derived: sum of 3 quarters · filed 2016-02-29
$4.35M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$6.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$9.22M
derived: sum of 2 quarters · filed 2016-02-29
$13.07M
derived: sum of 3 quarters · filed 2016-02-29
$2.09M
10-K · filed 2016-02-29
2013-09-30$2.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$6.82M
derived: sum of 2 quarters · filed 2014-11-10
-$4.16M
10-Q · filed 2014-11-10
$2.27M
derived: sum of 4 quarters · filed 2015-03-09
2013-06-30$3.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
-$7.13M
10-Q · filed 2014-08-08
-$691.00K
derived: sum of 3 quarters · filed 2015-03-09
$1.42M
derived: sum of 4 quarters · filed 2015-03-09
2013-03-31-$10.98M
10-Q · filed 2014-05-12
-$4.54M
derived: sum of 2 quarters · filed 2015-03-09
-$2.43M
derived: sum of 3 quarters · filed 2015-03-09
$1.56M
derived: sum of 4 quarters · filed 2015-03-09
2012-12-31$6.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
$8.55M
derived: sum of 2 quarters · filed 2015-03-09
$12.54M
derived: sum of 3 quarters · filed 2015-03-09
$1.65M
10-K · filed 2015-03-09
2012-09-30$2.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$6.11M
derived: sum of 2 quarters · filed 2013-11-08
-$4.79M
10-Q · filed 2013-11-08
$1.26M
derived: sum of 4 quarters · filed 2014-03-10
2012-06-30$4.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
-$6.90M
10-Q · filed 2013-08-06
-$853.00K
derived: sum of 3 quarters · filed 2014-03-10
-$43.00K
derived: sum of 4 quarters · filed 2014-03-10
2012-03-31-$10.89M
10-Q · filed 2013-05-03
-$4.85M
derived: sum of 2 quarters · filed 2014-03-10
-$4.04M
derived: sum of 3 quarters · filed 2014-03-10
-$3.67M
derived: sum of 4 quarters · filed 2014-03-10
2011-12-31$6.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10
$6.86M
derived: sum of 2 quarters · filed 2014-03-10
$7.22M
derived: sum of 3 quarters · filed 2014-03-10
-$3.30M
10-K · filed 2014-03-10
2011-09-30$810.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
$1.18M
derived: sum of 2 quarters · filed 2012-11-01
-$9.35M
10-Q · filed 2012-11-01
-$9.24M
10-Q · filed 2011-11-04
-$2.82M
derived: sum of 4 quarters · filed 2013-03-08
2011-06-30$365.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
-$10.16M
10-Q · filed 2012-08-03
-$10.15M
10-Q · filed 2011-08-05
-$3.63M
derived: sum of 3 quarters · filed 2013-03-08
-$639.00K
derived: sum of 4 quarters · filed 2013-03-08
2011-03-31-$10.53M
10-Q · filed 2012-05-04
-$3.99M
derived: sum of 2 quarters · filed 2013-03-08
-$1.00M
derived: sum of 3 quarters · filed 2013-03-08
2010-12-31$6.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08
$9.52M
derived: sum of 2 quarters · filed 2013-03-08
$6.17M
10-K · filed 2013-03-08
2010-09-30$2.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
-$356.00K
10-Q · filed 2011-11-04
2010-06-30-$3.35M
10-Q · filed 2011-08-05
2009-12-31$3.40M
10-K · filed 2012-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45